Clinical Trials Insight: 700059343

Trial Profile

Clinical Trials Insight: 700059343

Phase of Trial: Phase III

Latest Information Update: 16 Sep 2010

At a glance

  • Drugs Zolmitriptan (Primary)
  • Indications Migraine
  • Focus Registrational; Therapeutic Use
  • Sponsors APR Applied Pharma Research
  • Most Recent Events

    • 16 Sep 2010 This study has been successfully completed, and data from the trial will be used in submissions for registration in Europe, according to a media release from APR Applied Pharma Research and Labtec.
    • 16 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top